“Phase 3 Trial Demonstrates That MC2-01 Cream Has Improved Treatment Efficacy Compared to Calcipotriene Plus Betamethasone Dipropionate Topical Suspension in Patients With Mild to Moderate Psoriasis Vulgaris”. 2020. SKIN The Journal of Cutaneous Medicine 4 (5): s36. https://doi.org/10.25251/skin.4.supp.36.